Is Eledon Pharmaceuticals Inc (ELDN) a Smart Choice in Biotechnology Tuesday?

A rating of 86 puts Eledon Pharmaceuticals Inc (ELDN) near the top of the Biotechnology industry according to InvestorsObserver. Eledon Pharmaceuticals Inc's score of 86 means it scores higher than 86% of stocks in the industry. Eledon Pharmaceuticals Inc also received an overall rating of 68, putting it above 68% of all stocks. Biotechnology is ranked 58 out of the 148 industries.

ELDN has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on ELDN!

See Full ELDN Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Eledon Pharmaceuticals Inc Stock Today?

Eledon Pharmaceuticals Inc (ELDN) stock is down -2.85% while the S&P 500 is up 0.29% as of 1:16 PM on Tuesday, Oct 31. ELDN has fallen -$0.05 from the previous closing price of $1.58 on volume of 71,115 shares. Over the past year the S&P 500 has gained 7.93% while ELDN has fallen -36.10%. ELDN lost -$5.98 per share the over the last 12 months. Click Here to get the full Stock Report for Eledon Pharmaceuticals Inc stock.